Comparative genomics of Escherichia coli isolated from patients with inflammatory bowel disease

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Vejborg, Rebecca M ^a   Hancock, Viktoria ^a   Petersen, Andreas M ^b   Krogfelt, Karen A ^c   Klemm, Per ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Escherichia coli; Inflammatory bowel disease; LF82; Urinary tract infections

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CDT GENE; COMPARATIVE GENOMIC HYBRIDIZATION; CROHN DISEASE; ESCHERICHIA COLI; GENOMIC ISLAND; HETEROZYGOTE; HLY GENE; HUMAN; HUMAN CELL; NONHUMAN; PAP GENE; SFA GENE; ULCERATIVE COLITIS; BACTERIAL GENOME; BIOFILM; COMPARATIVE STUDY; ENTERITIS; GENETICS; GENOMICS; INTESTINE; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; URINARY TRACT INFECTION;

ESCHERICHIA COLI;

ADHESIN; BIOLOGICAL MARKER;

ADHESINS, ESCHERICHIA COLI; BIOFILMS; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; ESCHERICHIA COLI; GENOME, BACTERIAL; GENOMICS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; URINARY TRACT INFECTIONS;

EID: 79958772364     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-316     Document Type: Article

References (42)

1. Loftus EVJ. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517. 10.1053/j.gastro.2004.01.063, 15168363.
2. Martin HM, Rhodes JM. Bacteria and inflammatory bowel disease. Curr Opin Infect Dis 2000, 13:503-509. 10.1097/00001432-200010000-00012, 11964821.
3. Bergman L, Krause U. The incidence of Crohn's disease in central Sweden. Scand J Gastroenterol 1975, 10:725-729.
4. Loftus EVJ, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002, 31:1-20. 10.1016/S0889-8553(01)00002-4, 12122726.
5. Mayberry JF, Probert CSJ, Jayanthi V, Shivananda S. Epidemiology of inflammatory disease: a European perspective. Inflammatory bowel disease 1991, London: Chapman and Hall, Anagnostides AA, Hodgson HJF, Kirsner JB.
6. Thornton JR, Emmett PM, Heaton KW. Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J 1979, 2:762-764. 10.1136/bmj.2.6193.762, 1596421, 519184.
7. Onderdonk AB, Richardson JA, Hammer RE, Taurog JD. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun 1998, 66:6022-6023. 108765, 9826389.
8. Rath HC, Ikeda JS, Linde HJ, Scholmerich J, Wilson KH, Sartor RB. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology 1999, 116:310-319. 10.1016/S0016-5085(99)70127-7, 9922311.
9. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR, Timmis KN, Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004, 53:685-693. 10.1136/gut.2003.025403, 1774050, 15082587.
10. Sokol H, Lepage P, Seksik P, Dore J, Marteau P. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol 2006, 44:3172-3177. 10.1128/JCM.02600-05, 1594675, 16954244.
11. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004, 127:412-421. 10.1053/j.gastro.2004.04.061, 15300573.
12. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998, 115:1405-1413. 10.1016/S0016-5085(98)70019-8, 9834268.
13. Matsuda H, Fujiyama Y, Andoh A, Ushijima T, Kajinami T, Bamba T. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J Gastroenterol Hepatol 2000, 15:61-68. 10.1046/j.1440-1746.2000.02045.x, 10719749.
14. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 1999, 67:4499-4509. 96770, 10456892.
15. Nash JH, Villegas A, Kropinski AM, Aguilar-Valenzuela R, Konczy P, Mascarenhas M, Ziebell K, Torres AG, Karmali MA, Coombes BK. Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC genomics 2010, 11:667. 10.1186/1471-2164-11-667, 3091784, 21108814.
16. Miquel S, Peyretaillade E, Claret L, de Vallee A, Dossat C, Vacherie B, Zineb EH, Segurens B, Barbe V, Sauvanet P, et al. Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. PloS one 2010, 5:e12714. 10.1371/journal.pone.0012714, 2941450, 20862302.
17. Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997, 11:853-858. 10.1046/j.1365-2036.1997.00225.x, 9354192.
18. Sonnenborn U, Schulze J. Actual clincal studies on the efficacy of a probiotic drug. Microecology and Therapy 1997, 26:211-220.
19. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999, 354:635-639. 10.1016/S0140-6736(98)06343-0, 10466665.
20. Hancock V, Dahl M, Klemm P. Probiotic Escherichia coli strain Nissle 1917 out-competes intestinal pathogens during biofilm formation. J Med Microbiol 2010, 59:392-399. 10.1099/jmm.0.008672-0, 20110388.
21. Vejborg RM, Friis C, Hancock V, Schembri MA, Klemm P. A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972. Mol Genet Genomics 2010, 283:469-484. 10.1007/s00438-010-0532-9, 20354866.
22. Vejborg RM, Hancock V, Schembri MA, Klemm P. Comparative genomics of urinary tract infectious Escherichia coli. Appl Environ Microbiol 2011, Accepted, March 9, 2011.
23. Petersen AM, Nielsen EM, Litrup E, Brynskov J, Mirsepasi H, Krogfelt KA. A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease. BMC Microbiol 2009, 9:171. 10.1186/1471-2180-9-171, 2736970, 19695087.
24. Lloyd AL, Henderson TA, Vigil PD, Mobley HL. Genomic islands of uropathogenic Escherichia coli contribute to virulence. J Bacteriol 2009, 191:3469-3481. 10.1128/JB.01717-08, 2681901, 19329634.
25. Martinez-Medina M, Naves P, Blanco J, Aldeguer X, Blanco J, Blanco M, Ponte C, Soriano F, Darfeuille-Michaud A, Garcia-Gil LJ. Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC). BMC Microbiology 2009, 9:202. 10.1186/1471-2180-9-202, 2759958, 19772580.
26. Eaves-Pyles T, Allen CA, Taormina J, Swidsinski A, Tutt CB, Eric Jezek G, Islas-Islas M, Torres AG. Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol 2008, 298:397-409. 10.1016/j.ijmm.2007.05.011, 17900983.
27. Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, Stappert D, Wantia N, Rodriguez N, Wagner H, et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nature medicine 2008, 14:399-406. 10.1038/nm1734, 18327267.
28. Schubert S, Norenberg D, Clermont O, Magistro G, Wieser A, Romann E, Hoffmann C, Weinert K, Denamur E. Prevalence and phylogenetic history of the TcpC virulence determinant in Escherichia coli. Int J Med Microbiol 2010, 300:429-434. 10.1016/j.ijmm.2010.02.006, 20547102.
29. Bronowski C, Smith SL, Yokota K, Corkill JE, Martin HM, Campbell BJ, Rhodes JM, Hart CA, Winstanley C. A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli. Microbiology 2008, 154:571-583. 10.1099/mic.0.2007/013086-0, 18227261.
30. Boudeau J, Barnich N, Darfeuille-Michaud A. Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol 2001, 39:1272-1284. 10.1111/j.1365-2958.2001.02315.x, 11251843.
31. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, Peeters H, Bommelaer G, Desreumaux P, Colombel JF, Darfeuille-Michaud A. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007, 117:1566-1574. 10.1172/JCI30504, 1868786, 17525800.
32. Adlerberth I, Hanson LA, Svanborg C, Svennerholm AM, Nordgren S, Wold AE. Adhesins of Escherichia coli associated with extra-intestinal pathogenicity confer binding to colonic epithelial cells. Microb Pathog 1995, 18:373-385. 10.1006/mpat.1995.0034, 8551941.
33. Wold AE, Thorssen M, Hull S, Eden CS. Attachment of Escherichia coli via mannose- or Gal alpha 1-4Gal beta-containing receptors to human colonic epithelial cells. Infect Immun 1988, 56:2531-2537. 259607, 2901402.
34. Smith JL, Fratamico PM, Gunther NW. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis 2007, 4:134-163. 10.1089/fpd.2007.0087, 17600482.
35. Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: "the other bad E coli". J Lab Clin Med 2002, 139:155-162. 10.1067/mlc.2002.121550, 11944026.
36. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004, 127:80-93. 10.1053/j.gastro.2004.03.054, 15236175.
37. Bachmann BJ. Derivations and genotypes of some mutant derivatives of Escherichia coli K-12. Escherichia coli and Salmonella: cellular and molecular biology 1996, 2460-2488. Washington, D.C.: American Society for Microbiology, Neidhardt FC, Curtiss III R, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS, Riley M, Schaechter M, Umbarger HE, 2.
38. Grozdanov L, Raasch C, Schulze J, Sonnenborn U, Gottschalk G, Hacker J, Dobrindt U. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 2004, 186:5432-5441. 10.1128/JB.186.16.5432-5441.2004, 490877, 15292145.
39. Vejborg RM, Bernbom N, Gram L, Klemm P. Anti-adhesive properties of fish tropomyosins. J Appl Microbiol 2008, 105:141-150. 10.1111/j.1365-2672.2007.03718.x, 18298539.
40. Gentleman R, Carey V, Bates D, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
41. Pedersen AG, Jensen LJ, Brunak S, Stærfeldt H-H, Ussery DW. A DNA structural atlas for Escherichia coli. J Mol Biol 2000, 299:907-930. 10.1006/jmbi.2000.3787, 10843847.
42. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555-4558. 10.1128/AEM.66.10.4555-4558.2000, 92342, 11010916.